BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

426 related articles for article (PubMed ID: 28606794)

  • 1. Antifibrotic Actions of Peroxisome Proliferator-Activated Receptor γ Ligands in Corneal Fibroblasts Are Mediated by β-Catenin-Regulated Pathways.
    Jeon KI; Phipps RP; Sime PJ; Huxlin KR
    Am J Pathol; 2017 Aug; 187(8):1660-1669. PubMed ID: 28606794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibitory effects of PPARγ ligands on TGF-β1-induced CTGF expression in cat corneal fibroblasts.
    Jeon KI; Phipps RP; Sime PJ; Huxlin KR
    Exp Eye Res; 2015 Sep; 138():52-8. PubMed ID: 26142957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitory effects of PPARγ ligands on TGF-β1-induced corneal myofibroblast transformation.
    Jeon KI; Kulkarni A; Woeller CF; Phipps RP; Sime PJ; Hindman HB; Huxlin KR
    Am J Pathol; 2014 May; 184(5):1429-45. PubMed ID: 24650561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A PPAR-Gamma Agonist Rosiglitazone Suppresses Fibrotic Response in Human Pterygium Fibroblasts by Modulating the p38 MAPK Pathway.
    Nuwormegbe SA; Sohn JH; Kim SW
    Invest Ophthalmol Vis Sci; 2017 Oct; 58(12):5217-5226. PubMed ID: 29049722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Troglitazone ameliorates high glucose-induced EMT and dysfunction of SGLTs through PI3K/Akt, GSK-3β, Snail1, and β-catenin in renal proximal tubule cells.
    Lee YJ; Han HJ
    Am J Physiol Renal Physiol; 2010 May; 298(5):F1263-75. PubMed ID: 20015942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TGF-beta1 targets the GSK-3beta/beta-catenin pathway via ERK activation in the transition of human lung fibroblasts into myofibroblasts.
    Caraci F; Gili E; Calafiore M; Failla M; La Rosa C; Crimi N; Sortino MA; Nicoletti F; Copani A; Vancheri C
    Pharmacol Res; 2008 Apr; 57(4):274-82. PubMed ID: 18346908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effects of peroxisome proliferators-activated receptor gamma agonists on transforming growth factor-beta1 and Smads signal pathway: experiment with rat renal fibroblasts].
    Wang WM; Liu F; Chen N
    Zhonghua Yi Xue Za Zhi; 2006 Mar; 86(11):740-4. PubMed ID: 16681946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 15-Deoxy-Δ-12, 14-prostaglandin J2 acts cooperatively with prednisolone to reduce TGF-β-induced pro-fibrotic pathways in human osteoarthritis fibroblasts.
    Vaamonde-Garcia C; Malaise O; Charlier E; Deroyer C; Neuville S; Gillet P; Kurth W; Meijide-Failde R; Malaise MG; de Seny D
    Biochem Pharmacol; 2019 Jul; 165():66-78. PubMed ID: 30936016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulating the balance between peroxisome proliferator-activated receptor gamma and beta-catenin signaling during adipogenesis. A glycogen synthase kinase 3beta phosphorylation-defective mutant of beta-catenin inhibits expression of a subset of adipogenic genes.
    Liu J; Farmer SR
    J Biol Chem; 2004 Oct; 279(43):45020-7. PubMed ID: 15308623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peroxisome proliferator-activated receptor-gamma (PPAR-gamma) agonists attenuate the profibrotic response induced by TGF-beta1 in renal interstitial fibroblasts.
    Wang W; Liu F; Chen N
    Mediators Inflamm; 2007; 2007():62641. PubMed ID: 18274641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Electrophilic peroxisome proliferator-activated receptor-gamma ligands have potent antifibrotic effects in human lung fibroblasts.
    Ferguson HE; Kulkarni A; Lehmann GM; Garcia-Bates TM; Thatcher TH; Huxlin KR; Phipps RP; Sime PJ
    Am J Respir Cell Mol Biol; 2009 Dec; 41(6):722-30. PubMed ID: 19286977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-fibrogenic effect of PPAR-γ agonists in human intestinal myofibroblasts.
    Koo JB; Nam MO; Jung Y; Yoo J; Kim DH; Kim G; Shin SJ; Lee KM; Hahm KB; Kim JW; Hong SP; Lee KJ; Yoo JH
    BMC Gastroenterol; 2017 Jun; 17(1):73. PubMed ID: 28592228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Troglitazone attenuates TGF-β1-induced EMT in alveolar epithelial cells via a PPARγ-independent mechanism.
    Zhou B; Buckley ST; Patel V; Liu Y; Luo J; Krishnaveni MS; Ivan M; DeMaio L; Kim KJ; Ehrhardt C; Crandall ED; Borok Z
    PLoS One; 2012; 7(6):e38827. PubMed ID: 22745681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. β-Catenin pathway is required for TGF-β1 inhibition of PPARγ expression in cultured hepatic stellate cells.
    Qian J; Niu M; Zhai X; Zhou Q; Zhou Y
    Pharmacol Res; 2012 Sep; 66(3):219-25. PubMed ID: 22706027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet-Derived Growth Factor and Transforming Growth Factor β1 Regulate ARDS-Associated Lung Fibrosis Through Distinct Signaling Pathways.
    Deng X; Jin K; Li Y; Gu W; Liu M; Zhou L
    Cell Physiol Biochem; 2015; 36(3):937-46. PubMed ID: 26088859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of transforming growth factor (TGF)-beta1-induced extracellular matrix with a novel inhibitor of the TGF-beta type I receptor kinase activity: SB-431542.
    Laping NJ; Grygielko E; Mathur A; Butter S; Bomberger J; Tweed C; Martin W; Fornwald J; Lehr R; Harling J; Gaster L; Callahan JF; Olson BA
    Mol Pharmacol; 2002 Jul; 62(1):58-64. PubMed ID: 12065755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peroxisome proliferator-activated receptor-gamma (PPAR-gamma) agonist inhibits transforming growth factor-beta1 and matrix production in human dermal fibroblasts.
    Zhang GY; Cheng T; Zheng MH; Yi CG; Pan H; Li ZJ; Chen XL; Yu Q; Jiang LF; Zhou FY; Li XY; Yang JQ; Chu TG; Gao WY
    J Plast Reconstr Aesthet Surg; 2010 Jul; 63(7):1209-16. PubMed ID: 19617014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antifibrotic role of PGC-1α-siRNA against TGF-β1-induced renal interstitial fibrosis.
    Wang JL; Chen CW; Tsai MR; Liu SF; Hung TJ; Yu-Ju-Hung ; Chang WT; Shi MD; Hsieh PF; Yang YL
    Exp Cell Res; 2018 Sep; 370(1):160-167. PubMed ID: 29913155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hydroxysafflor yellow A inhibits TGF-β1-induced activation of human fetal lung fibroblasts in vitro.
    Pan R; Zhang Y; Zang B; Tan L; Jin M
    J Pharm Pharmacol; 2016 Oct; 68(10):1320-30. PubMed ID: 27457091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PPARgamma agonists inhibit TGF-beta induced pulmonary myofibroblast differentiation and collagen production: implications for therapy of lung fibrosis.
    Burgess HA; Daugherty LE; Thatcher TH; Lakatos HF; Ray DM; Redonnet M; Phipps RP; Sime PJ
    Am J Physiol Lung Cell Mol Physiol; 2005 Jun; 288(6):L1146-53. PubMed ID: 15734787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.